The review weighs weight and metabolic benefits in people with IBD against early lab hints of anti-inflammatory effects, and looks at what observational studies show so far.
Recap by typeshit. Full story at News-Medical.Net.
EMY covers findings suggesting GLP-1 drugs such as Wegovy could lower the risk of certain cancers. Details on which cancers are in the full story.
Shah points to research published September 2 in which older mice given semaglutide lived longer, with effects he says went beyond blood sugar control.
The obesity doctor takes on why some people see weaker results on GLP-1 medications. Short clip with few details given.
Researchers are starting to explain the shifts in libido some GLP-1 users report. The full story covers what scientists have found so far.
CFO MV Narasimham says the company still expects to ship 6 to 7 million pens across 10 approved markets between November and March, with Canada taking most of them.
14:03
An animated explainer from The Infographics Show on two sides of tirzepatide: who can actually get it, and the safety questions that come with it.
Loading…